Lobe Sciences Ltd. (LOBEF)

USD 0.0

(-77.67%)

Annual Income Statements

(In CAD)
Breakdown 2023 2022 2021 2020 2019 2017
Revenue 840.53 Thousand - - 884.83 Thousand 773.79 Thousand -
Cost of Revenue 24.01 Thousand 10.22 Thousand - - 2.21 Million -
Gross Profit 816.52 Thousand -10.22 Thousand - 884.83 Thousand -1.44 Million -
Operating Expenses 816.52 Thousand 4.12 Million 6.31 Million 3.29 Million 3.63 Million 51.93 Thousand
Selling, General and Administrative Expenses 2.88 Million 3.69 Million 4.94 Million 2.73 Million 3.26 Million 51.93 Thousand
Research and Development Expenses 1.24 Million 418.34 Thousand 1.37 Million - - -
Other Expenses - -2.63 Million 2293.00 -42.01 Thousand -1.7 Million -
Cost and Expenses 4.19 Million 4.12 Million 6.31 Million 3.29 Million 3.63 Million 51.93 Thousand
Operating Income -3.35 Million 1.36 Million 11.21 Million -2.45 Million -4.4 Million -51.93 Thousand
Interest Expense 38.64 Thousand - - 43.04 Thousand - 144.00
Income Tax Expense 205 Thousand 5.49 Million -1.02 Million 1034.00 -1.54 Million -
Earnings before Tax -4.5 Million -12.25 Million -23.84 Million -3.43 Million -754.43 Thousand -51.79 Thousand
Net Income -4.7 Million -12.25 Million -9.65 Million -3.43 Million -754.43 Thousand -51.79 Thousand
Earnings Per Share Basic -0.05 -0.32 -0.30 -0.27 -0.09 -0.07
Earnings Per Share Diluted -0.05 -0.32 -0.30 -0.27 -0.09 -0.07
Weighted Average Shares Outstanding 104.35 Million 37.86 Million 32.49 Million 12.55 Million 7.96 Million 733.9 Thousand
Weighted Average Shares Outstanding (Diluted) 104.35 Million 37.86 Million 32.49 Million 12.55 Million 7.96 Million 733.9 Thousand
Gross Margin 0.97 - - 1.00 -1.86 -
EBIT Margin -5.26 - - -2.14 -5.42 -
Profit Margin -5.60 - - -3.88 -0.97 -
EBITDA -4.42 Million 1.37 Million -6.15 Million -3.4 Million -4.19 Million -148.39 Thousand
Earnings Before Tax Margin -4.00 - - -2.77 -5.69 -

Income Statement Charts